Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
MoonLake Immunotherapeutics has filed 329 SEC EDGAR filings since 28 Aug 2020

SEC filing history

Showing 51-75 of 329 matching filings.

Per page
25
Current page
3
SCHEDULE 13G File 005-91803

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2026
Reporting date
07 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2026
Reporting date
07 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2026
Reporting date
07 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
08 Jan 2026
Reporting date
08 Jan 2026
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39630

144 filing

Filing date
08 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39630

144 filing

Filing date
08 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91803

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91803

SCHEDULE 13G filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91803

SCHEDULE 13D/A filing

Filing date
10 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
Next action
Verify source filing
424B5 File 333-274286

PROSPECTUS SUPPLEMENT

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91803

SCHEDULE 13G/A filing

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Oct 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91803

SCHEDULE 13G/A filing

Filing date
01 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Oct 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
29 Sep 2025
Reporting date
29 Sep 2025
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .